Calliditas Therapeutics AB (publ)
CALT
NASDAQ
| Weiss Ratings | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.40 | |||
| Price History | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $43.00 | |||
| 52-Week Low Price | $15.25 | |||
| 52-Week Low Price (Date) | Nov 13, 2023 | |||
| 52-Week High Price (Date) | Sep 20, 2024 | |||
| Valuation | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | 1.11B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.85 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 14.27 | |||
| Price/Book (Q) | 214.48 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 53.69M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 46 84 11 30 05 | |||
| Address | -- | |||
| Website | www.calliditas.se | |||
| Country | Sweden | |||
| Year Founded | 2004 | |||
| Profitability | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -23.28% | |||
| Profit Margin | -30.18% | |||
| Management Effectiveness | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -13.55% | |||
| Return on Equity | -- | |||
| Income Statement | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 150.52M | |||
| Total Revenue (TTM) | 150.52M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 140.69M | |||
| EBITDA (TTM) | -34.70M | |||
| EBIT (TTM) | -35.04M | |||
| Net Income (TTM) | -45.43M | |||
| Net Income Avl. to Common (TTM) | -45.43M | |||
| Total Revenue Growth (Q YOY) | 104.56% | |||
| Earnings Growth (Q YOY) | 49.16% | |||
| EPS Diluted (TTM) | -0.85 | |||
| EPS Diluted Growth (Q YOY) | 49.20% | |||
| Balance Sheet | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 75.22M | |||
| Cash Per Share (Q) | $1.40 | |||
| Total Current Assets (Q) | 108.92M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 10.08M | |||
| Current Ratio (Q) | 2.686 | |||
| Book Value Per Share (Q) | $0.19 | |||
| Total Assets (Q) | 164.85M | |||
| Total Current Liabilities (Q) | 40.55M | |||
| Total Debt (Q) | 95.13M | |||
| Total Liabilities (Q) | 154.77M | |||
| Total Common Equity (Q) | 10.08M | |||
| Cash Flow | CALT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.29M | |||
| Cash from Financing (TTM) | 18.44M | |||
| Net Change in Cash (TTM) | -6.71M | |||
| Levered Free Cash Flow (TTM) | -19.99M | |||
| Cash from Operations (TTM) | -23.37M | |||
